Company attributes
Industry
Location
B2X
0
CEO
AngelList URL
Pitchbook URL
Legal Name
RenovoRx, Inc.0
Accelerator
Accelerator Batch
Number of Employees (Ranges)
1 – 10
Phone Number
+165028444330
Full Address
4546 El Camino Real Suite B1 Los Altos, CA 940220
CIK Number
Place of Incorporation
Investors
DUNS Number
0334619940
IRS Number
271,448,4520
Founded Date
2013
0Fax Number
(650) 397-44330
Total Funding Amount (USD)
10,000,000
Latest Funding Round Date
May 2018
Stock Symbol
RNXT0
Exchange
Board of Directors
CFO
CAGE Code
66BA10
Patents Assigned (Count)
7
Wellfound ID
Country
Other attributes
Company Operating Status
Active
Contact Page URL
SIC Code
2,8340
Ticker Symbol
RNXT0
RenovoRx, a biopharmaceutical company headquartered in Silicon Valley, California, has developed a therapy platform to deliver chemotherapy, to difficult-to-treat tumors. Targeted therapy via the proprietary RenovoRx Trans-Arterial Micro-Perfusion (RenovoTAMP) platform safely and without transmission to non-targeted areas, is the primary focus. RenovoRx’s patent portfolio currently includes six issued US patents and one European patent for its technology with several additional patents pending in the US, Europe, and Asia.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
